- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Brain+ A/S: Brain+ selected for the NHS Dementia Innovators Programme in the UK | 134 | GlobeNewswire (Europe) | Copenhagen, Denmark, 5 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has been selected for the Dementia Innovators Programme in the United Kingdom (UK),... ► Artikel lesen | |
| BRAIN+ A/S Aktie jetzt für 0€ handeln | |||||
| 29.04. | BRAIN+ A/S: Brain+ publishes its Annual Report for 2024 | 3 | Cision News | ||
| 16.04. | Brain+ A/S: Brain+ appoints CCO Devika Wood as new CEO | 167 | GlobeNewswire (Europe) | Copenhagen, Denmark, 16 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S ("Brain+" or the "Company") announces that the Board has appointed the Company's Chief Commercial Officer (CCO)... ► Artikel lesen | |
| 09.04. | BRAIN+ A/S: Brain+ announces directed issue of units to convertible loan providers and guarantors | 1 | Cision News | ||
| 03.04. | BRAIN+ A/S: Contract signed with Copenhagen Municipality on extended and expanded access to Ayla | 2 | Cision News | ||
| 02.04. | Brain+ A/S: Brain+ announces outcome of unit rights issue | 63 | GlobeNewswire (Europe) | Copenhagen, Denmark, 2 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen | |
| 26.03. | BRAIN+ A/S: Brain+ A/S informs of last day to subscribe in its ongoing rights issue of units | 1 | Cision News | ||
| 25.03. | BRAIN+ A/S: Brain+ to close first UK Care Home partnership contract with Southcare Homes Group | 1 | Cision News | ||
| 19.03. | Brain+ A/S: Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators | 89 | GlobeNewswire (Europe) | Copenhagen, Denmark, 19 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") today reports continued strong momentum in its sales pipeline, now exceeding €500... ► Artikel lesen | |
| 17.03. | BRAIN+ A/S: The subscription period in Brain+' rights issue of units begins today | 1 | Cision News | ||
| 11.03. | BRAIN+ A/S: UK care sector expert, Vishal Shah joins Brain+ as Advisor and Board Observer | 1 | Cision News | ||
| 10.03. | BRAIN+ A/S: The benefits of Ayla - your CST Assistant featured in CareTech, the healthtech media for Danish healthcare professionals | 1 | Cision News | ||
| 06.03. | Brain+ A/S: Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million | 114 | GlobeNewswire (Europe) | Copenhagen, Denmark, 6 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen | |
| 24.02. | Brain+ A/S - reduction of share capital by reducing face value per share | 130 | GlobeNewswire | The nominal share capital of Brain+ A/S will be reduced as of 26 February 2025 by reducing the face value of the company's shares from DKK 0.08 to DKK 0.01.
Name:
Brain+
ISIN:
DK0061670205
Short... ► Artikel lesen | |
| 12.02. | Brain+ A/S: Brain+ A/S - Minutes of Extraordinary General Meeting | 111 | GlobeNewswire (Europe) | Copenhagen, Denmark, 12 February 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Today at 08:00 CEST, an Extraordinary General Meeting was held in Brain+ A/S ("Brain+" or "the Company"). A total of... ► Artikel lesen | |
| 30.01. | BRAIN+ A/S: Invitation to Investor Webinar to update on sales outlook, restructuring and secured funding | 4 | Cision News | ||
| 28.01. | BRAIN+ A/S: Brain+ A/S - Notice of Extraordinary General Meeting | 1 | Cision News | ||
| 22.01. | Brain+ A/S: Brain+ restructures to reduce OPEX by 35%, maintaining €1M ARR target for end 2025 and now expecting break-even by mid-2026, and announces 50% secured intended Rights Issue | 121 | GlobeNewswire (Europe) | Copenhagen, Denmark, 22 January 2025 - Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S ("Brain+" or the "Company") announces that today, its Board of Directors has decided to carry out a rights issue... ► Artikel lesen | |
| 31.12.24 | BRAIN A/S: Brain+ announces change of Certified Advisor | 2 | Cision News | ||
| 10.12.24 | BRAIN A/S: Brain+ invites to investor webinar to update on UK commercial pipeline and status | 2 | Cision News |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,170 | -0,07 % | Fresenius SE & Co. KGaA-Aktie: Kurs heute nahezu konstant (42,53 €) | Der Kurs der dem Anteilsschein von Fresenius SE & Co. KGaA kommt kaum von der Stelle. Zuletzt zahlten Investoren für das Papier 42,53 Euro. Wenig getan hat sich heute bislang beim Kurs von Fresenius+Co... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 15,520 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,360 | -0,47 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 50,30 | -0,04 % | Fresenius Medical Care-Aktie: Sie rüttelt am 12-Monatshoch | Mit einem Kursgewinn von über +5% ist die Fresenius Medical Care-Aktie am Dienstagmorgen die klare Nummer 1 unter den DAX-Werten. Hat der Dialysespezialist so starke Zahlen geliefert und steht nun bald... ► Artikel lesen | |
| GENEDX | 57,36 | 0,00 % | GeneDx Announces Completion of Fabric Genomics Acquisition | Closing unlocks the next phase of genomic medicine, enabling an end-to-end centralized and decentralized model for offering clinically-actionable genomic insights at a global scale
GAITHERSBURG,... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 17,050 | 0,00 % | Castle Biosciences, Inc.: Castle Biosciences to Acquire Previse | Expected to complement Castle's current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 23,060 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HIMS & HERS HEALTH | 44,740 | -3,37 % | Hims & Hers Health: Explosion am Gesundheitsmarkt | Der Markt für virtuelle medizinische Versorgung erlebt einen tiefgreifenden Umbruch. Immer mehr Anbieter setzen auf individuelle Therapien, schnelle Verfügbarkeit und ein nahtloses Nutzererlebnis. Besonders... ► Artikel lesen | |
| GERRESHEIMER | 60,65 | +2,45 % | Delivery Hero, Gerresheimer, Hugo Boss, Nagarro, Puma, Siltronic u.a. - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 59,80 | +2,22 % | EQS-Adhoc: Carl Zeiss Meditec AG: Wechsel im Vorstandsvorsitz der Carl Zeiss Meditec AG | EQS-Ad-hoc: Carl Zeiss Meditec AG / Schlagwort(e): Personalie
Wechsel im Vorstandsvorsitz der Carl Zeiss Meditec AG
07.05.2025 / 14:36 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 52,99 | 0,00 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
| UNITEDHEALTH | 346,90 | +0,30 % | UnitedHealth Group Incorporated (UNH): Among David Tepper's Stock Picks with Huge Upside Potential | ||
| GOODRX | 3,790 | 0,00 % | KeyBanc maintains GoodRx stock Overweight with $6 target | ||
| LIFEMD | 8,020 | 0,00 % | Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 | ||
| ECKERT & ZIEGLER | 58,40 | -0,26 % | EQS-PVR: Eckert & Ziegler SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Eckert & Ziegler SE
Eckert & Ziegler SE: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
02.05.2025 / 21:06 CET/CEST
Veröffentlichung... ► Artikel lesen |
BRAIN+ A/S gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRAIN+ A/S finden Sie auf Wallstreet Online.